Skip to main content
SunBio, Inc. logo

SunBio, Inc. — Investor Relations & Filings

Ticker · 067370 ISIN · KR7067370007 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2026-04-23 Director's Dealing
Country KR South Korea
Listing KO 067370

About SunBio, Inc.

http://www.sunbio.com/

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a statutory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (“Report on the Ownership of Specific Securities by Officers and Major Shareholders”). It provides details of an officer’s shareholdings, changes in holdings, transaction dates, and quantities. This matches the definition of “Director's Dealing” (Code: DIRS), which covers insider share transactions by directors and executives.
2026-04-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서,” which is a regulatory report filed with the securities commission and stock exchange disclosing an executive’s and major shareholder’s shareholdings and changes thereto. It lists the insider’s name, relationship, share counts before and after a transaction, and transaction details (e.g., 장내매수 on 2026.03.26). This matches our “Director's Dealing” category for insider trades by company directors/executives, not a full annual report or earnings release. Therefore, the correct classification is DIRS.
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official results of the company’s Annual General Meeting held on 2026-03-24, showing resolutions passed, vote counts and percentages, financial statement approvals, dividend resolutions and other shareholder meeting details. This aligns exactly with a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-24 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for SunBio Co., Ltd. for the fiscal year ending December 31, 2025. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements, nor is it a report announcement (RPA) as it contains the full content of the audit and financial data. FY 2025
2026-03-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details the share transactions (specifically '장내매수' or on-market purchases) by an executive (CEO Noh Kwang) of SunBio Co., Ltd. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data, and auditor information for the fiscal year ending 2025-12-31. While it contains financial data, it is a standardized regulatory disclosure form announcing the receipt and filing of the audit report rather than the full annual report document itself. Therefore, it is classified as an Audit Report / Information (AR) filing. FY 2025
2026-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.